An interest-driven account of Embryonic Stem Cell Research would, given the considerable financial and scientific concerns, likely predict regulations to converge towards permissive policies. However, across Western Europe, national regulations of embryonic stem-cell research vary considerably, from general bans to permissive policies. There is a lack of systematic accounting for the non-convergence, and the sparse attempts at explanation are contradictory.
Since the early stages in the development of human biotechnology, the differences in regulations across Western Europe intrigued and puzzled comparative public policy scholars. Regulatory paths on human biotechnology diverge substantially and this is also the case for regulating Embryonic Stem Cell Research (ESCR).
2 Given the economic and scientific potential of human biotechnology and the increased international competition in R&D activities (National Science
Board 2012 3 ; Ernest & Young 2011), purely economic and interest-driven accounts of policy trajectory would predict minimal state regulation combined with strong promotional activities (Banchoff 2005: 204; Tiberghien 2009 ). However, while some countries -in Asia (e,g. India,
Singapore, South Korea) and Europe (Belgium, the UK) -as well as some American States have adopted minimal regulations, other countries, such as France, Germany or Italy, have opted for a highly restrictive regulatory framework to govern ESCR. The convergence hypothesis arguing that the increased international scientific and economic competition would make state regulations converge towards minimal regulation has therefore proven to be wrong with respect to ESCR in Western Europe. The question then arises as to how to explain that policies have not converged across countries after two decades of ECRS research.
Our contribution sheds some light, not on why policies converge, but on why policies don't converge when one would expect them to do so. The literature on policy diffusion has spent a great deal of time on showing and explaining why policies converge. It has only recently moved toward investigating why policy diffusion does not necessarily result into policy convergence (Knill 2005; Radaelli 2005; Brooks 2007 ). For biomedical policies, Banchoff (2005) and Jasanoff (2005) have argued that previous policies on embryo research and assisted reproduction explain the lack of convergence. Banchoff's (2005) through small-N case study comparison has shown that negative policy feedback leads to policy stability or only incremental change. Other comparative studies have resulted in competing explanations for the variation in embryo research science (Fink 2008; Gottweis et al. 2009; Bleiklie et al. 2004; Montpetit et al. 2007 ).
These contradictory results reveal the need for systematic, comparative research that attempts to explain the lack of convergence in regulatory approaches for ESCR (see Engeli et al. 2012a) . In most studies, the hypotheses are not tested systematically, beyond the comparison of a limited number of qualitative case studies and cover too short a period in order to actually investigate policy trajectory (see Banchoff 2005) . This article contributes to a systematic analysis of how the principal explanatory factors evoked in the literature jointly lead to diverging regulations.
Drawing on Comparative Qualitative Analysis methodology (QCA, Ragin 2000 , 2008 , we cover 22 regulations of ESCR in Western Europe between 1998 and 2011. Taking the regulation as the unit of analysis, we investigate how value-driven path dependence in combination with party politics and public opinion, two other prominent factors evoked in the literature, lead to diverging regulatory paths in the case of ESCR.
Theoretical framework: Party politics, public opinion or path-dependency?
Comparative studies on human biotechnology have relied on the policy process theories, historical institutionalism, religion and politics and morality politics literatures. Given the variety of theoretical approaches used in the research, the findings have been contradictory and many explanations have proven to be at best weak. Among the various factors evoked in the literature, our analysis focuses on the three approaches that have been most prominent to explain the regulation of human biotechnology in Western Europe: path-dependency, party politics and public opinion. A first path to explaining current ESCR policies looks at past policy experiences. Path dependency (Pierson 2000 (Pierson , 2006 or policy heritage (Rose and Davis 1993) approaches are thus of particular relevance. More 'advanced' techniques such as ESCR can easily be assimilated to earlier debates and policies on ART and embryo research (Banchoff 2005; Jasanoff 2005 ).
PATH-DEPENDENCY EXPLANATION
Banchoff's work has successfully demonstrated that past policies on embryo research impacted ESCR policies in Germany and the United Kingdom. They influenced not only the actor constellation, but also the "terms of policy controversy" (Banchoff 2005: 211) . In line with his findings, first, we argue that there is a lock-in effect related to the considerable cost of debating 'moral' policy issues. Debating over ESCR strongly polarizes political actors, and also potentially divides political parties and governmental coalitions. Thus, sticking to an already established consensus prevents from reopening any policy debate and reduces the odds of severe internal divide within political parties or governmental coalitions (Banchoff 2005: 209-211) . Furthermore, policies already in place have an impact on actor constellations. They give a comparative advantage to those defending the status quo in comparison to forces seeking fundamental policy change (Pierson 2000; Banchoff 2005: 208-209 
PARTY POLITICS EXPLANATION
Qualitative case studies on the impact of past policy frames on ECRS or other biomedical issues focus exclusively on cases where a strong politicization of the issue can be observed. However, as the most recent research on morality policy demonstrates, the degree of politicization varies considerably depending on the political cleavages characterizing a political system. First, the comparative literature on biomedicine pointed to the importance of partisan politics, but argued that there is no clear cut connection between the composition of the government and the policy outcome (Varone et al. 2006) . The most recent research on morality policy successfully revisited this argument. Engeli, Green-Pedersen and Larsen (2012b) show that because morality issues touch upon basic questions of the beginning and the end of life, whether the religious cleavage structures a party system or not, is an important factor for understanding the "conflict definition"
of morality policy issues. In other words, the presence of Christian Democratic parties or a Conservative party with religious ties is crucial for understanding policy-making processes for morality policies. Indeed, the secular vs. the religious world, as the authors demonstrate, generate different agenda-setting patterns and conflict definitions. In the religious world compared to the secular world, as Engeli et al. (2012b) demonstrate, embryo and ESCR are more likely to be politicized. We argue that Christian Democrats in particular are likely to have an interest in the politicization of ESCR. In order to broaden their electoral appeal in a strongly secularized environment, for many issues parties with religious ties would opt for policy solutions that are not necessarily based on religious values; however, for the issue of ESCR, it is more likely that they adopt an unsecular strategy, trying to appeal to their core religious voters. Given the challenge of adapting to the process of secularization without losing their religious identity and core electoral The left-right cleavage is also of relevance for understanding policy outcomes for ESCR (Fink 2008 (Fink : 1635 . 4 While, at the beginning of the biotechnology revolution, biomedical issues were sometimes associated with biotechnology and its impact on the environment in general (Rothmayr and Serdült 2004; Rothmayr and Ramjoué 2004) 
PUBLIC OPINION EXPLANATION
There is a long tradition in democratic theory that emphasizes the impact of public opinion (Berry et al. 1998; Dahl 1989; Page and Shapiro 1983) and recent research on policy change has shown that political leaders are influenced by public majority while making policy choices (Burstein and Lincoln 2002; Soroka and Wlezien 2010) . Within the comparative literature on biomedicine and biotechnology, besides institutional factors in terms of past policy choices and partisan explanations, public opinion broadly defined as attitudes, beliefs and opinions on political and social issues, has also emerged as a prominent explanation for policy outcomes (Jasanoff 2005 , Gottweis 1998 Bernauer 2003; Fink 2008) . The findings on the importance of public opinion for biomedical policies are in line with recent research results on the public opinionpublic policy nexus over the last decades: public opinion does matter for explaining policy outcomes and policy change (Burstein 1998; Burstein and April 2002; Burstein and Lincoln 2002; Soule 2004; Soroka and Wlezien 2010; Brooks and Manza 2007; Stimson et al. 1995 In terms of attitudes towards science, Nielsen et al. (2002) have argued that there are two types of resistance towards biotechnology, traditional blue (religious) and modern green (environmental) forms of resistance. As various case studies reveal (see discussion of H3), green resistance towards biotechnology applications is often based on a critical attitude towards science and technological progress in general (Brossard and Nisbet 2007) . And in fact, independently of the concrete biotechnology application on the political agenda, low trust in scientific experts and skepticism of the benefits of technological progress help to explain the more critical evaluation of the potential benefits of ESCR versus the potential risks of the new technology (Ho et al. 2008) .
Science and technology studies also point to the fact that attitudes change over time, initial negative evaluations or resistance can fade over time as the benefits of new technology become more evident or the science better and more widely understood (Nisbet 2005) . Hence, we propose to test a fifth and last hypothesis:
H5: The more positive public opinion evaluates scientific progress, the more likely are policies without any severe restrictions.
DATA AND METHODS
In this section, we first present our dependent variable, the policy decisions on ESCR, and then discuss the independent variables and the Fs/QCA methodology. The Netherlands, Germany, Switzerland, The United Kingdom, Denmark, Sweden, Norway, Finland, Iceland, Greece). We are considering all the legally binding and explicit policy decisions that have been made on ESCR in these countries since the first successful derivation of embryonic stem cells in 1998. 6 We conceptualize medical and scientific autonomy as the degree of freedom granted to doctors and researchers to conduct ESCR and the conditions under which research should be conducted (Engeli et al. 2012a) . Three regulatory components are taken into account: First, different types of embryo can be used for ESCR. Permissive regulation allows for creating embryos for research-purpose while restrictive policies only allow for research on imported stem cell lines from other countries. The grounds for research are the second regulatory component. Permissive regulations do not constrain research to specific grounds whereas restrictive ones ban research with the exception of a limited number of therapeutic and observational research. Finally, permissive regulatory frameworks require a general authorization for being allowed to conduct ESCR, but do not impose an approval procedure specific to each research project as restrictive regulatory frameworks require.
We have coded the policies according to an additive index of the three regulatory components (equal weighting). The calibrated into fuzzy-set scores goes from 0 (ban), 0. 
Figure 1: Regulatory divergences on ESCR across Western Europe
There is a clear pattern of policy diffusion. All Western European countries but two -Austria and Ireland -have designed policies to address regulatory issues in the field of ESCR over the last 15 years. Nevertheless, across Western Europe, the policy diffusion has not resulted in convergence towards a generally permissive regulation. On the contrary, confronted with rapid and cuttingedge developments in human biotechnology, governments have adopted strongly diverging policies, ranging from fully prohibiting ESCR to broad permissiveness. In addition, most countries have not radically changed their policy over time. Three clusters of countries can be distinguished. The United Kingdom, Belgium, Iceland, and Sweden form the permissive cluster.
All these countries have adopted very permissive policies that allow for the creation of embryos for research purposes under the condition of a general permit to conduct ESCR granted to the research team or the research center. The restrictive cluster covers the countries that have imposed a general ban on ESCR or severe restrictions. In Italy, the current legislation explicitly bans embryo research and does not allow for any exception, even for non-harmfulresearch.
Switzerland and Norway initially banned ESCR and then later moved towards a less restrictive regulation and adopted a regulation similar to Spain, France, Denmark and Germany, whereby the creation of embryos for research purposes is banned, and severe restrictions are imposed on the use of leftover or imported embryos for ESCR, which has to be systematically approved. Finally, the third cluster of countries has adopted an intermediate approach. Finland, Greece and Portugal have banned the creation of embryos soley for research purposes, but do not impose severe restrictions on the use of leftover embryos. The Netherlands constitutes a particular case - first, the number of policies is limited and the size of the N (=22) does not allow for robust regression analysis; second, the literature emphasizes different explanations and this suggests that the analysis should move beyond monocausality and instead investigate the patterns in the configurational impact of different combinations of factors that may lead to a similar outcome. To this end, we draw on configurational comparative methods, and in particular Fuzzy-set Qualitative Comparative Analysis (FsQCA), which is increasingly used in comparative public policy research (for a review, see Rihoux 2012) . Configurational comparative methods allows for simultaneously benefitting from the complexity of each case, while helping to identify causal processes that could lead to middle-range generalization (Ragin 2000 (Ragin , 2008 . Before describing the FsQCA procedure applied to this analysis, we first discuss the explanatory variables. Due to words-constraint, can only describe the general principles of operationalization and refer for details to the methodological appendix.
To test the first of the two hypotheses addressing the importance of party politics, we have operationalized the causal condition "importance of the religious cleavage" as the strength of the religious parties in the party system. In most systems, religious parties are, most of the time, not strong enough to access government but can still impact on the policy making process in the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Turning to public opinion-based explanations, the importance of religious values within the society is measured by the classic survey question measuring the moral attitude towards the justifiability of abortion together with the aggregate level of religiosity of the society. The public's opinion on science is captured through the public's attitude on scientific advances.
Finally, the impact of prior ART regulation is measured through the medical autonomy granted to physicians to decide upon both the technology to be used and the conditions to be applied to treatment (Varone et al. 2006: 319-20 (column "N") that each configuration of causes displays and then by the level of consistency (column "consistency"), that is, the degree to which a causal combination of condition is a subset of the outcome. 9 As we aim to analyze permissive and restrictive policies, the classification of configurations will be explained when presenting the results for the two outcomes. The second step of the FsQCA procedure analyzes the truth table and reduces the logical complexity.
Drawing on the Quine-McClusky algorithm (Ragin 2008) , the aim of the second step is to identify the sufficient path(s) leading to the outcome (here, permissive policies) and to the negation of the outcome (here, restrictive policies). Table 2 presents the results of the minimization of the causal conditions leading to permissive and restrictive policies on ESCR. The N being relatively small, a frequency cut-off of 1 was adopted and every configuration has been taken into account in the analysis of the permissive regulatory paths. To compensate, a consistency value of 1.00 was set as benchmark criteria to distinguish between positive and negative outcomes in our 22 empirical cases. The FsQCA minimization procedure computes at least two different solutions. The parsimonious solution includes both the empirical cases and the logical remainders, while the complex solution is computed on the basis of the empirical cases only. As our N is relatively small, the complex solution based on the empirical cases displays more robust results and we will concentrate the discussion of the findings on this solution exclusively.
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EXPLAINING THE DIVERGING REGULATORY PATHS OVER ESCR
The complex solution reveals that four different paths result into permissive policies. As the paths display a great deal of similarity in the causal combinations, we focus the discussion on our series of three competing explanations. The major finding resulting from the analysis of the causal in the Netherlands a coalition government has followed the same regulatory path.
[ Table 2 : Sufficient paths towards permissive and restrictive policies]
Due to space-related constraints, we cannot develop the qualitative explanation for all the cases with permissive outcomes and have to focus instead on one empirical case in order to illustrate our main finding on the importance of value-based path dependence. In the Netherlands, ART treatments has benefited from strong public support since the beginning of the 1980s and the number of ART centers has increased rapidly (Timmermans and Scholten 2006; Timmermans 2007) . During the 1980s and 90s, the government refrained from any restrictive intervention in the field of ART and instead only issued procedural decrees. When the technological breakthroughs in embryo-related research during the 1990s put the issue back on the political The analysis of the restrictive regulatory paths in the field of ESCR across Western Europe largely confirms our main findings for permissive outcomes. For the minimization of the configuration of conditions leading to restrictive policies, as before, the frequency cut-off is set to 1 and the consistency cut-off to 0.88. Here again, the systematic effect of value-based path dependence is striking. Both the parsimonious and complex solutions stress the importance of the absence of a permissive ART regulation to account for restrictive ESCR policies, the negated condition "path_art" being present in all the restrictive paths. Nevertheless, the restrictive regulatory paths allows for a more fine-grained understanding of the contribution of religious factors to human biotechnology policies. Among the countries that have adopted restrictive regulations, Christian Democrats and more generally, religious-based parties, have been traditionally weak in France and Denmark while they have been stronger in Germany, Switzerland, Italy and also in Norway. In Norway, the Christian Democrats were not institutionally strong enough to exert any decisive impact on the regulation and that is why this condition is absent of the path. On the contrary, in Germany and Switzerland, Christian
Democrats have successfully made pressure for restricting embryo-related research more severely than ART in general. The German and Swiss cases are both characterized by an early and broad mobilization against ART and biotechnology more generally (see Rothmayr and Serdült 2004; Rothmayr and Ramjoué 2004; Engeli and Varone 2011) . In neither case did the debate focus on give to the defenders of the status quo. In short, on the one hand, our analysis confirms the findings of Banchoff (2005) . But, on the other hand, they also reveal the importance of the moral dimension of ESCR policies, by pointing to the influence of religious cleavages in party systems, as well as the public's religious attitudes. There again, our findings align with results of prior research, by Fink (2008) emphasising religious values, and more recently by Engeli et al. (2012b) on the importance of religious cleavages in party systems. However, in contrast to these prior studies, through the systematic comparison of 22 regulatory frameworks over 13 years, we were able to show the configurational impact of different combinations of factors that may lead to a similar outcome. The Fuzzy-set Qualitative Comparative Analysis (FsQCA) allowed to combine The principal purpose of this article is to discuss why there has been no convergence for ECSR.
However, one might ask to what extent the explanatory factors we evoked were also responsible for assisted reproductive technology policies in the first place. 11 Economic and research competition do not play the same important role for regulating ART in general, than they do for ECRS. Hence, for ART policies, there is no expectation of convergence in the literature. As we pointed out in the introduction and the theoretical framework, we find various competing explanations in past research. Indirectly, our results confirm the importance of religious cleavages structuring party systems and public opinion. At the same time, because there are various paths leading to permissive or restrictive policies, clearly these factors alone are not sufficient to explain policy outcomes. This explains, at least partly, why case study based research has resulted in competing explanations, because indeed, in function of the countries studied a different combination of factors accounts for policy outcomes.
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APPENDIX: FS/QCA CALIBRATION
The appendix presents the measurement and calibration of the dependent and independent variables modeled in the Fs/QCA analysis for our article in JEPP.
A. OUTCOME: EMBRYONIC STEM CELL RESEARCH (ESCR) REGULATIONS IN WESTERN EUROPE
In this analysis, our dependent variable, the outcome in Fs/QCA terminology, is the policies on ESCR adopted in the major Western European Countries (Portugal, Spain, France, Italy, Belgium,
The Netherlands, Germany, Switzerland, The United Kingdom, Denmark, Sweden, Norway, Finland, Iceland, Greece) . We are considering all the legally binding and explicit policy decisions that have been made on ESCR in these countries. Accordingly, we have excluded two major European countries -Austria and Ireland. In these countries, no binding and explicit regulations on ESCR have been elaborated so far. As the literature points out (Engeli et al. 2012; Fink 2008; Bleiklie et al. 2004; Montpetit et al. 2008) The unit of analysis being the policy decision, our N covered 22 decisions in 15 countries. 9
countries have only made, so far, one single decision on ESCR while 6 countries have taken more than one decision (The United Kingdom: 2; Spain: 2; Greece: 2; Norway: 3; The Netherlands: 2;
Switzerland: 2).
We conceptualize medical and scientific autonomy as the degree of freedom granted to doctors and researchers to conduct ESCR and the conditions under which research should be conducted (Engeli et al. 2012a) . Three regulatory components are taken into account: (Indicator 1) the type of embryo that can be used for ESCR, (Indicator 2) the grounds for conducting research and (Indicator 3) the approval procedure for research.
Indicator 1: First, the regulations differ with respect to the type of embryo that can be used to derive embryonic stem cells lines. Permissive regulation allows for creating embryos specifically for ESCR and the derivation of stem cell lines. Intermediate policies only allow for conducting research on leftover embryos resulting from the termination of IVF treatment or then limit research to embryos and embryos imported from other countries. Finally, restrictive policies ban the use of embryos and only allow research conducted on imported stem cell lines.
Indicator 2: Second, regarding the grounds for research, permissive regulations do not constrain research to specific grounds, whereas restrictive ones ban research with the exception of a limited number of therapeutic ground research. Intermediate regulation spells out a series of permitted grounds in an explicit way. We built up an additive index of the three indicators ((Indicator 1 + Indicator 2+ Indicator 3)/3) with equal weighting -the index has a minimum of 0 and a maximum of 3. We have then rescaled the index into the 4-value fuzzy-set score as follows: total bans are assigned a fuzzy-set score of 0 (index score: 0.00), restrictive regulations a score of 0.33 (index scores: 1.00, 1.33), intermediate regulations a score of 0.67 (index scores 2.00, 2.33) and permissive regulation a score of 1 (index score: 3.00). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 47 48 (2011)'s definition of religious parties. As the number of cases is small, it was not methodologically feasible to keep the original scale that was going from 0% to 36.6%. Instead, we have calibrated it into a 4-value fuzzy-set condition as follows. Religious parties holding less than 10% of seats are calibrated to a fuzzy-set score of 0 as their low representation in parliament does not provide them with a strong capacity to influence the decision-making process in a decisive way on their own. Religious parties holding more than 20% of parliamentary seats represent a powerful parliamentary group that plays a preponderant role in the bargaining process over the regulation. A direct conversion would not capture this important qualitative gap. Accordingly, we have opted for a 4-value fuzzy-set condition instead and better account for the qualitative difference in being a minor member of a cabinet coalition, a major member or being in full power. 
"PUBLIC OPINION" CONDITIONS
Attitude toward the human embryo
There is no public opinion data on ESCR available that would cover the whole time period and the entire set of countries included in our study. The best proxy available is the attitude toward abortion. As ESCR addresses the issue of the status of the human embryo is a similar way than the abortion issue does (i.e. the derivation of stem cells implies the destruction of the embryo), we have thus decided to rely on public opinion measure of attitudes toward abortion as a proxy. We 
Church Attendance
There is no annual data regarding church attendance available that covers the entire time period and set of countries included in our study. In a similar way as for 'opinion on human embryo', we therefore rely on the 5-wave World Value Survey data and use an indicator of the aggregate proportion of citizens who attend church services at least once per month, which goes from 7.9% to 54.2%. We recalibrated into a 4-value fuzzy-set condition and set the cutting-off points every 11.6% increase (i.e. (maximum value -minimum value)/4) as the original quantitative displays a normal distribution. The World Value Survey dataset is a 5-wave dataset. We used data from the most recent survey wave immediately preceding the relevant policy decision year. 
Attitude toward science advance
There is no public opinion data on attitudes toward scientific advancement available that would cover the entire time period and set of countries included in our study. We thus rely also on the 5-wave World Value Survey data and use an indicator of the proportion of respondents who consider that "in the long run, the scientific advances we are making will help mankind". As science advance data are more finely gradated than the embryo and church attendance data, we recalibrated into a 6-value fuzzy-set condition (instead of a 4-value condition) and set the cuttingoff points every 8.45% increase (i.e. (maximum value -minimum value)/4). The World Value Survey dataset is a 5-wave dataset. We used data from the most recent survey wave immediately preceding the relevant policy decision year. 
